Heterologous expression and immunogenic potential of the most abundant phospholipase A2 from coral snake micrurus dumerilii to develop antivenoms

ABSTRACT: Micrurus dumerilii is a coral snake of clinic interest in Colombia. Its venom is mainly composed of phospholipases A2 being MdumPLA2 the most abundant protein. Nevertheless, Micrurus species produce a low quantity of venom, which makes it difficult to produce anticoral antivenoms. Therefor...

Full description

Autores:
Romero Giraldo, Luz Elena
Pulido Muñoz, Sergio Andrés
Berrío, Mario A.
Flórez González, María Fernanda
Rey Suárez, Jessica Paola
Núñez Rangel, Vitelbina
Pereañez Jiménez, Jaime Andrés
Tipo de recurso:
Article of investigation
Fecha de publicación:
2022
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/41406
Acceso en línea:
https://hdl.handle.net/10495/41406
Palabra clave:
Antivenenos
Antivenins
Serpientes de Coral
Coral Snakes
Venenos Elapídicos - enzimología
Elapid Venoms - enzymology
Ratones
Mice
Fosfolipasas A2
Phospholipases A2
Conejos
Rabbits
Proteínas Recombinantes
Recombinant Proteins
https://id.nlm.nih.gov/mesh/D000997
https://id.nlm.nih.gov/mesh/D000073181
https://id.nlm.nih.gov/mesh/D004546
https://id.nlm.nih.gov/mesh/D051379
https://id.nlm.nih.gov/mesh/D054467
https://id.nlm.nih.gov/mesh/D011817
https://id.nlm.nih.gov/mesh/D011994
Rights
openAccess
License
http://creativecommons.org/licenses/by/2.5/co/
Description
Summary:ABSTRACT: Micrurus dumerilii is a coral snake of clinic interest in Colombia. Its venom is mainly composed of phospholipases A2 being MdumPLA2 the most abundant protein. Nevertheless, Micrurus species produce a low quantity of venom, which makes it difficult to produce anticoral antivenoms. Therefore, in this work, we present the recombinant expression of MdumPLA2 to evaluate its biological activities and its immunogenic potential to produce antivenoms. For this, a genetic construct rMdumPLA2 was cloned into the pET28a vector and expressed heterologously in bacteria. His-rMdumPLA2 was extracted from inclusion bodies, refolded in vitro, and isolated using affinity and RP-HPLC chromatography. His-rMdumPLA2 was shown to have phospholipase A2 activity, a weak anticoagulant effect, and induced myonecrosis and edema. The anti-His-rMdumPLA2 antibodies produced in rabbits recognized native PLA2, the complete venom of M. dumerilii, and a phospholipase from another species of the Micrurus genus. Antibodies neutralized 100% of the in vitro phospholipase activity of the recombinant toxin and a moderate percentage of the myotoxic activity of M. dumerilii venom in mice. These results indicate that His-rMdumPLA2 could be used as an immunogen to improve anticoral antivenoms development. This work is the first report of an M. dumerilii functional recombinant PLA2.